Journal
/
/
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
JoVE Journal
Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Biology
Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
DOI:

10:20 min

June 16, 2008

Chapters

  • 00:07Title
  • 00:59What are limitations of today’s antiretroviral therapies
  • 01:41Excision of proviral DNA. Targeting LTR specific sequences.
  • 03:39Addressing the problem of multiple HIV isolates.
  • 04:35Generation of site-specific Tre recombinase via directed molecular evolution.
  • 05:49Delivery of Tre recombinase, HIV-1 proviral DNA excision, and elimination of HIV-1 viruses.
  • 06:39Open questions.
  • 08:21Towards a clinical application.

Summary

Automatic Translation

Current HIV-1 strategies act to suppress the viral life cycle but do not effectively eradicate infection. Here, we demonstrate that an engineered recombinase can efficiently excise integrated HIV-1 proviral DNA from the genome of infected cells.

Related Videos

Read Article